Description
Artemisinin resistance was first identified in Cambodia in 2008. In the Mekong region, once
artemisinin resistance has spread widely, it is often followed by resistance to its associated
drugs, leading to failure of combination therapy. This resistance is associated with parasites
carrying genetic mutations. Despite a denial of resistance to artemisinin and other
antimalarials in Africa by the World Health Organization and other institutions such as the
Pasteur Institute, health professionals are still alerted to this resistance.
In this article, we present a non-exhaustive literature on the reports of resistance to Artemisinin
and other antimalarials in Africa.
The researchers point out that the emergence of partial artemisinin resistance in Africa is
an alarm of a great public health danger, if these resistance to related drugs spread rapidly
in Africa, the effectiveness of treatment could be compromised. Recent data from Africa
suggest that we are on the verge of clinically significant artemisinin resistance.
That African policy makers and researchers reflect on alternative malaria treatments in
Africa. We need to accelerate research on medicinal plants including Artemisia annua and
afra in Africa.
| Contact Geneva Health Forum | I just want to receive information about the GHF 2024 conference / Je souhaite simplement recevoir des informations sur la conférence GHF 2024 |
|---|
